0 projects

ENERGIX-Stort program energi

H2ACCELERATE - Fast-tracking advanced PEM electrolysis materials and monitoring

Grønt hydrogen vil muliggjøre en overgang fra fossile energikilder til fornybare energikilder. PEM-elektrolyse er en av nøkkelteknologiene for konvertering av fornybar energi til hydrogen og teknologien har et stort vekstpotensiale. Det viktigste for videre vekst av denne teknologien er reduksjon...

Awarded: NOK 6.1 mill.

Project Period: 2022-2024

Location: Oslo

BIA-Brukerstyrt innovasjonsarena

Blood microRNAs for the early diagnosis of Alzheimers disease

Occurence of miRNA in blood specific for a number of different diseases including neurological diseases has been reported. We intend with this project to explore the potential of using an expression pattern with selected miRNAs isolated from whole blood, plasma or serum as biomarkers for the ear...

Awarded: NOK 0.25 mill.

Project Period: 2012-2013

Location: Oslo

BIA-Brukerstyrt innovasjonsarena

A gene expression signature for the early detection of Parkinson disease

The diagnosis of PD today relies on a physicians exam. Autopsy studies, however, have demonstrated that even experienced neurologists misdiagnose PD in about a quarter out of a hundred cases. Diagnostic accuracy at disease onset, when neuroprotective trea tment is anticipated to be most effective...

Awarded: NOK 5.0 mill.

Project Period: 2009-2013

Location: Oslo

FUGE-Funksjonell genomforskn.i Norg

Developing blood-based gene expression tests for early diagnosis of Alzheimer's disease

Alzheimer's disease (AD) is the most common form of dementia affecting some 28 mill. people worldwide. Medical interventions in the pipeline that can delay the onset or progression of this disease will have enormous public health impacts. An accurate, obj ective, easy to use test for early detect...

Awarded: NOK 9.8 mill.

Project Period: 2006-2008

Location: Oslo

FUGE-Funksjonell genomforskn.i Norg

Development of a stable and robust assay for early detection of breast caner using gene expression technology and peripheral blood sample

Breast cancer is the most common form of cancer in women, and early detection is a key for successful treatment and survival. DiaGenic AS (“DiaGenic”) is developing a gene expression based assay for early detection of breast cancer using blood as clinica l sample. The studies conducted so far s...

Awarded: NOK 9.2 mill.

Project Period: 2003-2008

Location: Oslo